HUP0004544A2 - Angiotenzin-átalakító enzim inhibitora és diuretikum kombinációjának alkalmazása mikrokeringési rendellenességek kezelésére szolgáló gyógyászati készítmény előállítására - Google Patents

Angiotenzin-átalakító enzim inhibitora és diuretikum kombinációjának alkalmazása mikrokeringési rendellenességek kezelésére szolgáló gyógyászati készítmény előállítására

Info

Publication number
HUP0004544A2
HUP0004544A2 HU0004544A HUP0004544A HUP0004544A2 HU P0004544 A2 HUP0004544 A2 HU P0004544A2 HU 0004544 A HU0004544 A HU 0004544A HU P0004544 A HUP0004544 A HU P0004544A HU P0004544 A2 HUP0004544 A2 HU P0004544A2
Authority
HU
Hungary
Prior art keywords
diuretic
converting enzyme
enzyme inhibitor
pharmaceutical composition
microcirculation disorders
Prior art date
Application number
HU0004544A
Other languages
English (en)
Inventor
David Guez
Bernard Levy
Pierre Schiavi
Original Assignee
Adir Et Compagnie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adir Et Compagnie filed Critical Adir Et Compagnie
Publication of HUP0004544A2 publication Critical patent/HUP0004544A2/hu
Publication of HUP0004544A3 publication Critical patent/HUP0004544A3/hu
Publication of HU226022B1 publication Critical patent/HU226022B1/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/556—Angiotensin converting enzyme inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

A találmány tárgyát angiotenzin-átalakító enzim inhibitora (CEI) ésegy diuretikum kombinációjának arteriolo-kapilláris mikrokeringésirendellenességek kezelésére alkalmas gyógyászati készítményekelőállítására történő alkalmazása képezi. Ó
HU0004544A 1997-11-19 1998-03-03 Process for preparation pharmaceutical composition combination of hypertensin converting enzyme inhibitor with a diuretic for treating microcirculation disorders HU226022B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9714485A FR2771010B1 (fr) 1997-11-19 1997-11-19 Utilisation d'une combinaison d'un inhibiteur de l'enzyme de conversion de l'angiotensine et d'un diuretique pour le traitement des desordres microcirculatoires
PCT/FR1998/000411 WO1999025374A1 (fr) 1997-11-19 1998-03-03 Combinaison d'un inhibiteur de l'enzyme de conversion de l'angiotensine et d'un diuretique pour le traitement des desordres microcirculatoires

Publications (3)

Publication Number Publication Date
HUP0004544A2 true HUP0004544A2 (hu) 2001-06-28
HUP0004544A3 HUP0004544A3 (en) 2001-07-30
HU226022B1 HU226022B1 (en) 2008-03-28

Family

ID=9513523

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0004544A HU226022B1 (en) 1997-11-19 1998-03-03 Process for preparation pharmaceutical composition combination of hypertensin converting enzyme inhibitor with a diuretic for treating microcirculation disorders

Country Status (21)

Country Link
US (1) US6653336B1 (hu)
EP (1) EP1032414B1 (hu)
JP (1) JP2001523646A (hu)
CN (1) CN1227029C (hu)
AT (1) ATE239500T1 (hu)
AU (1) AU740748B2 (hu)
BR (1) BR9814885A (hu)
CA (1) CA2310136C (hu)
DE (1) DE69814444T2 (hu)
DK (1) DK1032414T3 (hu)
EA (1) EA002968B1 (hu)
ES (1) ES2198708T3 (hu)
FR (1) FR2771010B1 (hu)
HK (1) HK1033096A1 (hu)
HU (1) HU226022B1 (hu)
NO (1) NO20002479L (hu)
NZ (1) NZ504220A (hu)
PL (1) PL340561A1 (hu)
PT (1) PT1032414E (hu)
WO (1) WO1999025374A1 (hu)
ZA (1) ZA986673B (hu)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2811320B1 (fr) * 2000-07-06 2002-08-23 Adir Nouvelle forme cristalline alpha du sel de tert-butylamine du perindopril, son procede de preparation et les compositions pharmaceutiques qui la contiennent
FR2811319B1 (fr) * 2000-07-06 2002-08-23 Adir Nouvelle forme cristalline beta du sel de tert-butylamine du perindopril, son procede de preparation et les compositions pharmaceutiques qui la contiennent
FR2811318B1 (fr) * 2000-07-06 2002-08-23 Adir Nouvelle forme cristalline gamma du sel de tert-butylamine du perindopril, son procede de preparation et les compositions pharmaceutiques qui la contiennent
US20040156903A1 (en) * 2002-05-22 2004-08-12 Abrams Andrew L.. Metering and packaging of controlled release medication
CA2448997A1 (en) * 2001-05-31 2002-12-05 Microdose Technologies, Inc. Metering and packaging of controlled release medication
FR2841140B1 (fr) * 2002-06-24 2004-10-01 Servier Lab Microcapsules pour la liberation retardee et controlee du perindopril
GB2423927A (en) * 2003-08-29 2006-09-13 Cotherix Inc Combination Of Cicletanine And An Oral Antidiabetic And/Or Blood Lipid-Lowering Agent For Treating Diabetes And Metabolic Syndrome
CN1292747C (zh) * 2003-09-16 2007-01-03 广东省心血管病研究所 一种用于治疗高血压的复方制剂
DE102004019845A1 (de) * 2004-03-29 2005-10-20 Krka Tovarna Zdravil D D Verfahren zur Herstellung einer festen pharmazeutischen Zusammensetzung
LT1729739T (lt) * 2004-03-29 2016-11-10 Les Laboratoires Servier Kietos farmacinės kompozicijos gamybos būdas
SI21800A (sl) 2004-05-14 2005-12-31 Krka, Tovarna Zdravil, D.D., Novo Mesto Nov postopek sinteze perindoprila
DE102004062257A1 (de) * 2004-12-23 2006-07-06 Merckle Gmbh Direkt verpresste Indapamid-Tabletten mit verzögerter Wirkstofffreisetzung
MY138209A (en) * 2005-03-11 2009-05-29 Servier Lab New (y) crystalline form of perindopril tert-butylamine salt, a process for its preparation and pharmaceutical compositions containing it.
BRPI0615607A2 (pt) * 2005-08-30 2011-05-24 Lek Pharmaceuticals composição farmacêutica compreendendo perindopril ou seus sais
DE102005058166A1 (de) * 2005-12-05 2007-06-06 Hexal Ag Matrixkontrolliertes transdermales System mit Amin-Salzen der ACE-Hemmer-Dicarbonsäuren
WO2008068577A2 (en) * 2006-12-01 2008-06-12 Glenmark Pharmaceuticals Limited Pharmaceutical compositions
SI22543A (sl) 2007-06-27 2008-12-31 Krka, Tovarna Zdravil, D.D., Novo Mesto Nove soli perindoprila
CN107496899A (zh) 2011-09-29 2017-12-22 梅约医学教育与研究基金会 芳族阳离子肽和使用它们的方法
RU2618471C2 (ru) * 2012-12-03 2017-05-03 Закрытое Акционерное Общество "Вертекс" Пероральная фармацевтическая композиция диуретика и ингибитора АПФ в микронизированной форме, лекарственное средство и его применение

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK9200258U4 (da) * 1992-03-11 1993-07-23 Merck & Co Inc Farmaceutisk præparat indeholdende enalapril til brug mod hypertension
WO1996028185A2 (en) * 1995-03-16 1996-09-19 Pfizer Inc. Composition containing amlodipine, or a salt, or felodipine and an ace inhibitor

Also Published As

Publication number Publication date
ES2198708T3 (es) 2004-02-01
ZA986673B (en) 1999-02-04
ATE239500T1 (de) 2003-05-15
CA2310136A1 (fr) 1999-05-27
AU740748B2 (en) 2001-11-15
DK1032414T3 (da) 2003-09-01
CN1279615A (zh) 2001-01-10
CA2310136C (fr) 2004-04-20
AU6837798A (en) 1999-06-07
EP1032414B1 (fr) 2003-05-07
NO20002479D0 (no) 2000-05-12
HUP0004544A3 (en) 2001-07-30
FR2771010B1 (fr) 2003-08-15
PL340561A1 (en) 2001-02-12
BR9814885A (pt) 2000-10-03
HK1033096A1 (en) 2001-08-17
EA200000536A1 (ru) 2000-10-30
CN1227029C (zh) 2005-11-16
DE69814444D1 (de) 2003-06-12
WO1999025374A1 (fr) 1999-05-27
PT1032414E (pt) 2003-08-29
HU226022B1 (en) 2008-03-28
NO20002479L (no) 2000-05-12
US6653336B1 (en) 2003-11-25
JP2001523646A (ja) 2001-11-27
EP1032414A1 (fr) 2000-09-06
NZ504220A (en) 2003-05-30
EA002968B1 (ru) 2002-12-26
FR2771010A1 (fr) 1999-05-21
DE69814444T2 (de) 2004-03-18

Similar Documents

Publication Publication Date Title
HUP0004544A2 (hu) Angiotenzin-átalakító enzim inhibitora és diuretikum kombinációjának alkalmazása mikrokeringési rendellenességek kezelésére szolgáló gyógyászati készítmény előállítására
RS50091B (sr) Upotreba retigabina u lečenju neuropatskog bola
AU6257798A (en) Treatment of arrhythmias via inhibition of a multifunctional calcium/calmodulin-dependent protein kinase
AU5861799A (en) Use of acetylcholinesterase inhibitors for the preparation of pharmaceutical compositions for the treatment of functional and/or organic pain syndromes
DE69331739D1 (de) Neuartige pharmazeutische verwendungen von krill-enzymen
HUP0100427A2 (hu) ACE inhibítor - MMP inhibitor-kombinációk
HUP0001014A2 (hu) Gasztrointesztinális lipáz inhibitorok felhasználása
HUP9901353A2 (hu) ACE-inhibitorok alkalmazása diszpepsziás tünetek kezelésére alkalmas gyógyszerkészítmény előállítására
AU1023497A (en) Tissue factor - kunitz domain fusion proteins as factor viia inhibitors
NO960775L (no) Anvendelse av kinoksaliner i kombinasjon med proteaseinhibitorer som legemiddel for behandling av AIDS og/eller HIV-infeksjoner
HUP0202729A2 (hu) Ösztramusztin-foszfátot és aminosavakat tartalmazó, parenteralis felhasználásra szolgáló készítmények
CA2250077A1 (en) Use of (+)-.alpha.-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol in treating depressive disorders and bipolar disorders
HUP9801075A2 (hu) Kombinált állandó dózisú angiotenzint átalakító enzim inhibítor kalciumcsatorna-antagonista, eljárás ennek előállítására, valamint alkalmazása szív- és érrendszeri betegségek kezelésében
ATE75610T1 (de) Pharmazeutische zubereitung zur behandlung des bluthochdrucks.
BR9608978A (pt) Inibidor de protease de serina derivado de imidazo [1,5a] piridina composição farmacêutica e utilização do inibidor de protease
HUP0102116A2 (hu) Paroxetin-aszkorbát, eljárás az előállítására és gyógyászati alkalmazása
HUP0100639A1 (hu) Humán alfa1-savas glikoprotein alkalmazása gyógyszerkészítmények előállítására
GB2318057A (en) Treatment of nocturnal polyuria using an ace inhibitor in combination with a diuretic
MX9800891A (es) Mocarhagina, una proteasa del veneno de cobra y usso terapeuticos de la misma.
UA9672A (uk) Спосіб лікування деструктивних форм гострого панкреатиту
PT99238A (pt) Processo para a preparacao de composicoes farmaceuticas contendo um inibidor da enzima conversora da angiotensina e um inibidor da actividade do tromboxano a2, utilizadas no tratamento de nefropatias
MX9605327A (es) Uso de ciertos derivados de acido metanbisfosfonico para prevenir el aflojamiento de las protesis y la emigracion de las protesis.
UA32580C2 (uk) Засіб для лікування паралітичної непрохідності кишечнику